{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:16:10Z","timestamp":1779279370220,"version":"3.51.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Tranexamic acid (TXA) is a widely used antifibrinolytic agent proven to reduce bleeding in many surgical settings. Its application in burn surgery is emerging; however, existing studies lack a comprehensive synthesis, making clinical translation challenging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic review was conducted according to preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines and registered on PROSPERO (ID: CRD42023443397). An electronic search of PubMed, Ovid MEDLINE, and Embase (August 2024) yielded 532 articles, of which 15 studies met the inclusion criteria. Eligible study designs included randomized controlled trials, observational studies, case reports\/series, and conference abstracts. Data on total blood loss, blood loss per area excised, hemoglobin levels, intraoperative fluid use, packed red blood cell transfusions, length of stay (LOS), complications, and mortality were extracted. Meta-analyses were performed using R (v4.4.1), and outcomes were reported as standardized mean differences (SMDs) or proportions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Meta-analysis of 7 studies on preoperative intravenous TXA demonstrated significant reductions in total blood loss (SMD \u20130.65;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0051), blood loss per area excised (SMD \u20133.66;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0069), intraoperative packed red blood cell units (SMD \u20130.48;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0019), and LOS (SMD \u20130.34;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0035). No significant differences were observed in any of the other outcomes. Data for topical TXA remain limited, although preliminary reports are encouraging.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Preoperative intravenous TXA may reduce surgical blood loss and intraoperative transfusions. Studies support a favorable safety profile. However, its impact on graft survival and overall transfusion needs is uncertain. Further research is warranted to optimize dosing, explore topical administration, and clarify subgroup effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/gox.0000000000007707","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:00:07Z","timestamp":1779278407000},"page":"e7707","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of the Use of Tranexamic Acid in Burn Patients: A Systematic Review and Meta-analysis"],"prefix":"10.1097","volume":"14","author":[{"given":"Kyle B.","family":"Mangum","sequence":"first","affiliation":[{"name":"Department of Surgery, Texas Tech University Health Science Center, Lubbock, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaina A.","family":"Eckert","sequence":"additional","affiliation":[{"name":"Department of Surgery, Texas Tech University Health Science Center, Lubbock, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osaid","family":"Alser","sequence":"additional","affiliation":[{"name":"Department of Surgery, Timothy J. Harnar Burn Center, Texas Tech University Health Science Center, Lubbock, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babafela B.","family":"Awosile","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Veterinary Medicine, Texas Tech University, Amarillo, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan B.","family":"Stuart","sequence":"additional","affiliation":[{"name":"Department of Surgery, Texas Tech University Health Science Center, Lubbock, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryce D.","family":"Stash","sequence":"additional","affiliation":[{"name":"Department of Surgery, Timothy J. Harnar Burn Center, Texas Tech University Health Science Center, Lubbock, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,5]]},"reference":[{"key":"R1-20260520","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.burns.2023.01.003","article-title":"Predicting blood loss in burn excisional surgery.","volume":"49","author":"Gigengack","year":"2023","journal-title":"Burns"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/jbcr\/irac002","article-title":"The impact of initial surgical management on outcome in patients with severe burns: a 9-year retrospective analysis.","volume":"43","author":"Zhu","year":"2022","journal-title":"J Burn Care Res"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"iraf021","DOI":"10.1093\/jbcr\/iraf021","article-title":"American Burn Association clinical practice guideline on blood product transfusion in burn care.","volume":"46","author":"Wallace","year":"2025","journal-title":"J Burn Care Res"},{"key":"R4-20260520","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.burns.2018.08.024","article-title":"Management of bleeding in major burn surgery.","volume":"45","author":"Welling","year":"2019","journal-title":"Burns"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jbcr\/irac114","article-title":"Reducing blood loss in a burn care unit: a review of its key determinants.","volume":"44","author":"Souto","year":"2023","journal-title":"J Burn Care Res"},{"key":"R6-20260520","doi-asserted-by":"crossref","first-page":"E179","DOI":"10.1002\/ajh.26940","article-title":"United States blood pricing: a cross-sectional analysis of charges and reimbursement at 200 US Hospitals.","volume":"98","author":"Jacobs","year":"2023","journal-title":"Am J Hematol"},{"key":"R7-20260520","doi-asserted-by":"crossref","first-page":"20503121211054995","DOI":"10.1177\/20503121211054995","article-title":"Assessing the global burden of hemorrhage: the global blood supply, deficits, and potential solutions.","volume":"9","author":"Raykar","year":"2021","journal-title":"SAGE Open Med"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"S301","DOI":"10.1111\/trf.16976","article-title":"Tranexamic acid: beyond antifibrinolysis.","volume":"62","author":"Prudovsky","year":"2022","journal-title":"Transfusion"},{"key":"R9-20260520","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/SLA.0000000000003793","article-title":"A single preoperative dose of tranexamic acid reduces perioperative blood loss: a meta-analysis.","volume":"273","author":"Heyns","year":"2021","journal-title":"Ann Surg"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"1284016","DOI":"10.3389\/fmed.2023.1284016","article-title":"Prehospital tranexamic acid in trauma patients: a systematic review and meta-analysis of randomized controlled trials.","volume":"10","author":"Acharya","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12871-024-02471-3","article-title":"Effectiveness of tranexamic acid in burn patients undergoing surgery\u2014a systematic review and meta-analysis.","volume":"24","author":"Slob","year":"2024","journal-title":"BMC Anesthesiol"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.burns.2023.05.009","article-title":"Tranexamic acid in burn surgery: a systematic review and meta-analysis.","volume":"49","author":"Fijany","year":"2023","journal-title":"Burns"},{"key":"R13-20260520","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/jbcr\/irac185","article-title":"Topical hemostatic agents in burn surgery: a systematic review.","volume":"44","author":"Battistini","year":"2023","journal-title":"J Burn Care Res"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"e3172","DOI":"10.1097\/GOX.0000000000003172","article-title":"A systematic review of tranexamic acid in plastic surgery: what\u2019s new?","volume":"9","author":"Elena Scarafoni","year":"2021","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"1253e","DOI":"10.1097\/PRS.0000000000011288","article-title":"Clinical applications of tranexamic acid in plastic and reconstructive surgery.","volume":"154","author":"Brown","year":"2024","journal-title":"Plast Reconstr Surg"},{"key":"R16-20260520","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation.","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"R17-20260520","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments.","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"R20-20260520","doi-asserted-by":"crossref","first-page":"107270","DOI":"10.1016\/j.burns.2024.09.009","article-title":"Effects of intravenous tranexamic acid on bleeding during burn surgery: a double-blinded randomized clinical trial.","volume":"51","author":"Naderi","year":"2025","journal-title":"Burns"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.burns.2021.08.021","article-title":"Effect of single dose intravenous tranexamic acid on blood loss in tangential excision of burn wounds\u2014a double blind randomised controlled trial.","volume":"48","author":"Ajai","year":"2022","journal-title":"Burns"},{"key":"R22-20260520","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.egja.2017.05.004","article-title":"Impact of single dose intravenous tranexamic acid on peri-operative blood transfusion requirements in burn patients: a prospective, randomized trial.","volume":"33","author":"Bhatia","year":"2017","journal-title":"Egypt J Anaesth"},{"key":"R23-20260520","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.burns.2022.03.002","article-title":"Tranexamic acid reduced blood transfusions in acute burn surgery: a retrospective case-controlled trial.","volume":"48","author":"Tapking","year":"2022","journal-title":"Burns"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"353","DOI":"10.23736\/S0375-9393.16.10992-7","article-title":"Transfusion requirements in burn patients undergoing primary wound excision: effect of tranexamic acid.","volume":"83","author":"Dominguez","year":"2017","journal-title":"Minerva Anestesiol"},{"key":"R25-20260520","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.burns.2022.07.002","article-title":"Management strategies for perioperative anaemia in the severely burn-injured Jehovah\u2019s Witness patients who decline a blood transfusion: a systematic review with illustrative case reports.","volume":"49","author":"Jung","year":"2023","journal-title":"Burns"},{"key":"R26-20260520","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1097\/BCR.0b013e3182a366c5","article-title":"Reducing postburn injury anemia in a Jehovah\u2019s witness patient.","volume":"35","author":"Barsun","year":"2014","journal-title":"J Burn Care Res"},{"key":"R27-20260520","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.burnso.2023.08.003","article-title":"A management strategy for burns surgery in hemophilia complicated by inhibitors: a case report.","volume":"7","author":"Kearney","year":"2023","journal-title":"Burns Open"},{"key":"R32-20260520","doi-asserted-by":"crossref","first-page":"e6074","DOI":"10.1097\/GOX.0000000000006074","article-title":"Topical tranexamic acid on donor wounds in burn patients: a randomized placebo-controlled trial.","volume":"12","author":"Colclough","year":"2024","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R33-20260520","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/jmms.jmms_25_20","article-title":"A study to evaluate reduction in blood loss by topical application of tranexamic acid in burn wound surgery.","volume":"23","author":"Mohan","year":"2021","journal-title":"J Marine Med Soc"},{"key":"R34-20260520","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bjps.2011.09.028","article-title":"Use of tranexamic acid to reduce bleeding in burns surgery.","volume":"65","author":"Tang","year":"2012","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R35-20260520","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bja.2021.10.054","article-title":"Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers.","volume":"128","author":"Grassin-Delyle","year":"2022","journal-title":"Br J Anaesth"},{"key":"R37-20260520","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s13054-021-03799-9","article-title":"Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: a systematic review and meta-analysis.","volume":"25","author":"Murao","year":"2021","journal-title":"Crit Care"},{"key":"R38-20260520","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)30848-5","article-title":"Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.","volume":"395","author":"Roberts","year":"2020","journal-title":"Lancet"},{"key":"R39-20260520","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMoa2201171","article-title":"Tranexamic acid in patients undergoing noncardiac surgery.","volume":"386","author":"Devereaux","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Plastic and Reconstructive Surgery - Global Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GOX.0000000000007707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:00:12Z","timestamp":1779278412000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GOX.0000000000007707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/gox.0000000000007707","relation":{},"ISSN":["2169-7574"],"issn-type":[{"value":"2169-7574","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2025-07-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}